NCT06975657

Well-being Skills for Reentry

Community-engaged Research to Promote Mental Health and Successful Reentry Outcomes Following Incarceration

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: University of Wisconsin, Madison · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to learn if a mindfulness skills training program has mental health benefits for people returning to the community following incarceration. The main questions it aims to answer are: * Does mindfulness skills training improve symptoms of anxiety and depression? * Do participants find this mindfulness program to be acceptable and feasible to participate in? Researchers will compare outcomes for participants in the mindfulness training program to those in a waitlist control group who will receive the mindfulness program after the end of the study. Participants will: * Complete an initial intake visit, consisting of an interview and questionnaires * Randomly be assigned to a mindfulness group or a waitlist control group * Participate in weekly mindfulness classes for 6 weeks (mindfulness group only) * Complete a set of questionnaires after the conclusion of the mindfulness classes * Complete a set of questionnaires and an interview 2 months after the conclusion of the mindfulness classes

Conditions

• Formerly Incarcerated Adults

Interventions

Type	Name	Description
BEHAVIORAL	Wellbeing skills for reentry	An 8-week, in-person meditation training program for formerly incarcerated adults, with practices and concepts grounded in the four pillars of the Healthy Minds Program (awareness, connection, insight, and purpose) that are supported by custom meditation practices presented in the Healthy Minds Program App.
DEVICE	Healthy Minds Program	A customized version of the Healthy Minds Program app will allow participants to listen to recorded meditation practices in support of the in-person curriculum.

Timeline

• Start date: 2026-01-12
• Primary completion: 2027-11-30
• Completion: 2027-11-30
• First posted: 2025-05-16
• Last updated: 2026-03-11

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study